SCHEMBL4466178

SCHEMBL4466178

NC(=O)CNc1ccncn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 1/20 0.47
MKNK1 Q9BUB5 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2D6 P10635 3/20 0.40
CYP2C9 P11712 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
CHRNB2 P17787 1/20 0.40
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA4 P43681 1/20 0.40
HTT P42858 1/20 0.40
HRH4 Q9H3N8 1/20 0.40
EPHX2 P34913 1/20 0.39
TDO2 P48775 1/20 0.39
GRIN2B Q13224 1/20 0.38
PRKCI P41743 1/20 0.37
NTRK1 P04629 1/20 0.37
ATR Q13535 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2401814 0.84 P2RX7 (0.44) P2RX7MKNK1SMN1; SMN2CYP3A4CYP2D6
SCHEMBL4419704 0.79 SMN1; SMN2 (0.48) P2RX7MKNK1SMN1; SMN2CYP3A4CYP2D6
SCHEMBL6259328 0.77 SMN1; SMN2 (0.40) P2RX7MKNK1SMN1; SMN2CYP3A4CYP2D6
SCHEMBL2857962 0.76 GAA (0.55) SMN1; SMN2CYP2D6CYP1A2CYP2C19
SCHEMBL5262945 0.76 CHRNB2 (0.50) P2RX7MKNK1CHRNB2CHRNB4CHRNA3
SCHEMBL31579540 0.76 CHRNB2 (0.50) P2RX7MKNK1CHRNB2CHRNB4CHRNA3
SCHEMBL7511801 0.74 CYP2C9 (0.46) P2RX7SMN1; SMN2CYP3A4CYP2D6CYP2C9
SCHEMBL5167269 0.73 MDM2 (0.48) CYP3A4CYP2D6CYP1A2CYP2C19PRKCI
SCHEMBL9272032 0.73 P2RX7 (0.36) P2RX7MKNK1EPHX2TDO2PRKCI
SCHEMBL5572160 0.73 KDM4E (0.50) SMN1; SMN2CYP2D6CYP2C9CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO claimed
WO-2008124085-A2 METHODS OF USING COMBINATIONS OF MEK AND JAK-2 INHIBITORS EXELIXIS, INC. (US) 2008-10-16 WO claimed
JP-2002241369-A 4-PYRIMIDINYLAMINOACETAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME DAINIPPON PHARMACEUT CO LTD 2002-08-28 JP disclosed